To access this element change to forms mode OFF
Grant Award View - GA85468
Ivermectin as an anti-viral against SARS-CoV-2
GA ID:
GA85468
Agency:
Department of Health and Aged Care
Approval Date:
29-May-2020
Publish Date:
23-Jun-2020
Category:
Health and Medical Research
Grant Term:
1-Jun-2020 to 31-May-2021
Value (AUD):
$344,458.70
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 19/20 1.1 Health Policy Research and Analysis
Grant Program:
2020_MRFF_Anti_Viral_COVID19
Grant Activity:
Ivermectin as an anti-viral against SARS-CoV-2
Purpose:
We have shown that the drug Ivermectin, which is already used in humans to treat a number of parasite infections, is also very effective at preventing the virus that causes COVID-19 from replicating. We have shown this in virus infecting cells in a laboratory and now we will confirm whether it is able to be used in people suffering from COVID-19. As ivermectin is already safe for use, if it is effective against the virus at these safe concentrations it can be rapidly moved into human trials.
GO ID:
GO Title:
MRFF – 2020 Antiviral Development for COVID-19 Grant Opportunity
Internal Reference ID:
MRF2002121
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA